Dudediligence.

Omeros Corporation

OMERNASDAQ · Pharmaceutical Preparations
Write an idea

Price

From the filings

Figures

Net income
$124.8Mlast 12 months
Operating cash flow
−$94.8Mlast 12 months
Cash and equivalents
$2.0Mat the last balance sheet
Total debt
$73.3Mat the last balance sheet
Shares outstanding
72.1M shareson issue
Every year and quarter →